Products Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine Approved Completed 🔥 Hot Pertussis Immunisation, Diphtheria Immunisation, Tetanus Immunisation, Poliomyelitis Vaccine
Jan 27, 2021 → Jan 11, 2023
About Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine is a approved stage product being developed by Sanofi for Pertussis Immunisation. The current trial status is completed. This product is registered under clinical trial identifier NCT04300192. Target conditions include Pertussis Immunisation, Diphtheria Immunisation, Tetanus Immunisation.
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT04300192 Approved Completed Jan 27, 2021 Jan 11, 2023 Pertussis Immunisation
Product Company Stage Hype Score Adacel® Sanofi Approved aP booster + TdaP booster + Licensed TdaP booster (Boostrix®) Novartis Phase 1 Boostrix + Placebo (Saline) Novartis Approved Acellular pertussis vaccine + Tetanus, reduced diphtheria, and acellular pertussis vaccine (adsorbed) + Licensed TdaP booster vaccine + Diphtheria and tetanus vaccine (adsorbed, reduced antigen content, Germany) Novartis Phase 1 Tetanus Toxoid, acellular pertussis, diphtheria toxoid Sanofi Pre-clinical ADACEL®:Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed + BOOSTRIX®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed Sanofi Approved COVAXIS™: Tetanus, diphtheria, acellular 5-component pertussis, or + inactivated poliovirus vaccine (REPEVAX®) Sanofi Approved (ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis Sanofi Phase 1/2 DT5aP-IPV-Hib 5-component Pertussis vaccine + Infanrix® -IPV+Hib Sanofi Phase 3 Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV + Hepatitis B vaccine Sanofi Phase 2 DTwP-HepB-Hib-IPV hexavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b, inactivated poliovirus) + DTwP-HepB-Hib pentavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b) + Inactivated Poliomyelitis Vaccine + Poliomyelitis Vaccine bivalent types 1 and 3 + Human Rotavirus, live attenuated + Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) Sanofi Phase 3 Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®) + Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®) Sanofi Approved Pentacel® (DTaP-IPV/Hib) + Other Pertussis Vaccines Sanofi Pre-clinical DTaP-IPV combined vaccine + DTaP vaccine Sanofi Phase 3 ADACEL®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed + DECAVAC®: Tetanus and Diphtheria Toxoids Adsorbed Sanofi Approved Tetanus and diphtheria toxoids and acellular pertussis Sanofi Pre-clinical
Other Products from Sanofi